Chair, Melissa L. Johnson, MD, Enriqueta Felip, MD, PhD, Prof. Hidetoshi Hayashi, MD, PhD, and Antonio Passaro, MD, PhD, discuss NSCLC in this CME activity titled “Taking Aim With the Next Wave of Antibody–Drug Conjugates in NSCLC: Rational Strategies for Addressing the Unmet Needs of Diverse Patient Populations With TROP2- and HER3-Targeting Therapies and Other ADC-Based Regimens.” For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/YMP865. CME credit will be available until October 11, 2024.
